TerminatedPhase 4

Study Evaluating Novel Biomarkers of AKI (Acute Kidney Injury) in Post-operative Patients

Stopped: No patients with renal failure

Belgium100 participantsStarted 2015-04-01

Plain-language summary

To validate the use of \[TIMP-2\]●\[IGFBP-7\] to predict AKI in patients undergoing major intra abdominal surgery.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ≥ 18 years * High risk patients: General Surgery AKI Risk Index Class III, IV or V * Major abdominal surgery Exclusion Criteria: * Ongoing acute kidney injury Stage 2/3 * History of kidney transplant

What they're measuring

Number of participants diagnosed with AKI stage 2 or 3 using the updated rifle "KDIGO" guidelines

Timeframe: 72 Hours

Trial details

NCT IDNCT02499185

SponsorUniversitair Ziekenhuis Brussel

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-07-31

View on ClinicalTrials.gov More Acute Kidney Injury trials